NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 343 filers reported holding NATERA INC in Q2 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,038,224 | +56.4% | 18,700 | -0.1% | 0.00% | +100.0% |
Q2 2022 | $664,000 | -90.6% | 18,726 | -89.2% | 0.00% | -80.0% |
Q1 2022 | $7,048,000 | -91.9% | 173,250 | -81.3% | 0.01% | -91.7% |
Q4 2021 | $86,719,000 | +91.8% | 928,608 | +128.9% | 0.06% | +71.4% |
Q3 2021 | $45,207,000 | +196.2% | 405,664 | +201.7% | 0.04% | +169.2% |
Q2 2021 | $15,263,000 | -68.1% | 134,441 | -71.5% | 0.01% | -71.7% |
Q1 2021 | $47,890,000 | +59.1% | 471,630 | +56.0% | 0.05% | +53.3% |
Q4 2020 | $30,093,000 | +757.4% | 302,380 | +522.3% | 0.03% | +650.0% |
Q3 2020 | $3,510,000 | +1579.4% | 48,591 | +1060.2% | 0.00% | – |
Q2 2020 | $209,000 | -97.6% | 4,188 | -98.6% | 0.00% | -100.0% |
Q1 2020 | $8,883,000 | -12.0% | 297,500 | -0.7% | 0.01% | +33.3% |
Q4 2019 | $10,096,000 | +24.1% | 299,657 | +20.8% | 0.01% | +12.5% |
Q3 2019 | $8,137,000 | -49.9% | 248,075 | -57.9% | 0.01% | -46.7% |
Q2 2019 | $16,246,000 | +39.8% | 589,036 | +4.5% | 0.02% | +25.0% |
Q1 2019 | $11,624,000 | – | 563,702 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |